Clément Denys, Morel Olivier, Malartic Cécile, Akerman Grégory, Barranger Emmanuel
Service de gynécologie-obstétrique, hôpital Lariboisière, 2, rue Ambroise-Paré, 75010 Paris.
Bull Cancer. 2007 Jul;94(7):675-9.
In cancer research, regional lymph node status is a major prognostic factor and a decision criterion for adjuvant therapy. The sentinel node procedure, which has emerged to reduce morbidity of extensive lymphadenectomy, remains a major step in the surgical management of various cancers. In endometrial cancer, the sentinel node biopsy is still at the stage of feasibility. The main problem of the diffusion of the sentinel node biopsy in endometrial cancer is the absence of injection site consensus. The different injection sites (myometrial, pericervical and hysteroscopy) allow to identify para-aortic lymph node drainage. In this article, we review the interest of hysteroscopic injection in endometrial cancer. This injection site could contribute to select the patients potentially being able to profit from a lombo-aortic lymphadenectomy.
在癌症研究中，区域淋巴结状态是一个主要的预后因素及辅助治疗的决策标准。前哨淋巴结手术旨在减少广泛淋巴结清扫术的发病率，仍是各种癌症手术治疗的重要步骤。在子宫内膜癌中，前哨淋巴结活检仍处于可行性阶段。前哨淋巴结活检在子宫内膜癌中推广的主要问题是缺乏注射部位的共识。不同的注射部位（肌层、宫颈旁和宫腔镜下注射）有助于识别腹主动脉旁淋巴结引流情况。在本文中，我们回顾了宫腔镜下注射在子宫内膜癌中的意义。该注射部位可能有助于筛选出有可能从腰主动脉淋巴结清扫术中获益的患者。
